UPDATE 2-Gilead hepatitis C sales beat Wall Street, sales outlook raised

* Product sales rise 27 percent to $8.1 billion (Adds company comment, updates share price)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.